Validation of early risk-prediction models for gestational diabetes based on clinical characteristics

Diabetes Research and Clinical Practice

Volumn 103, Issue 3, 2014, Pages 419-425

  Thériault, Sébastien ^a,b   Forest, Jean Claude ^a,b   Massé, Jacques ^a,b   Giguère, Yves ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Early pregnancy; External validation; Gestational diabetes mellitus; Prediction models; Risk factors

Indexed keywords

EARLY PREGNANCY; EXTERNAL VALIDATION; GESTATIONAL DIABETES MELLITUS; PREDICTION MODELS; RISK FACTORS;

ADULT; BODY MASS INDEX; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MODELS, STATISTICAL; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 84898640686     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.12.009     Document Type: Article

References (41)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee Canadian Diabetes Association 2008 Clinical Practice Guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008, 32(Suppl. 1):S1-S201.
2. Metzger B.E., Coustan D.R. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998, 21(Suppl 2):B161-B167.
3. Galtier F. Definition, epidemiology, risk factors. Diabetes Metab 2010, 36:628-651.
4. Metzger B.E., Gabbe S.G., Persson B., Buchanan T.A., Catalano P.A., Damm P., et al. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010, 33:676-682.
5. Jiwani A., Marseille E., Lohse N., Damm P., Hod M., Kahn J.G. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonat Med 2012, 25:600-610.
6. Dyck R., Klomp H., Tan L.K., Turnell R.W., Boctor M.A. A comparison of rates, risk factors, and outcomes of gestational diabetes between aboriginal and non-aboriginal women in the Saskatoon health district. Diabetes Care 2002, 25:487-493.
7. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007, 30(Suppl 2):S141-S146.
8. Beucher G., Viaris de Lesegno B., Dreyfus M. Maternal outcome of gestational diabetes mellitus. Diabetes Metab 2010, 36:522-537.
9. Mitanchez D. Foetal and neonatal complications in gestational diabetes: perinatal mortality, congenital malformations, macrosomia, shoulder dystocia, birth injuries, neonatal complications. Diabetes Metab 2010, 36:617-627.
10. Crowther C.A., Hiller J.E., Moss J.R., McPhee A.J., Jeffries W.S., Robinson J.S. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005, 352:2477-2486.
11. Landon M.B., Spong C.Y., Thom E., Carpenter M.W., Ramin S.M., Casey B., et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009, 361:1339-1348.
12. Burguet A. Long-term outcome in children of mothers with gestational diabetes. Diabetes Metab 2010, 36:682-694.
13. Verier-Mine O. Outcomes in women with a history of gestational diabetes. Screening and prevention of type 2 diabetes. Literature review. Diabetes Metab 2010, 36:595-616.
14. Thompson D., Berger H., Feig D., Gagnon R., Kader T., Keely E., et al. Diabetes and pregnancy. Can J Diabetes 2013, 37(Suppl 1):S168-S183.
15. Weinert L.S. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: comment to the International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Diabetes Care 2010, 33:e97. author reply e98.
16. Blackwell S.C. Counterpoint: enough evidence to treat? The american college of obstetricians and gynecologists guidelines. Clin Chem 2012, 58:1098-1100.
17. Coustan D.R. Point: the american diabetes association and the International Association of Diabetes and Pregnancy Study Groups recommendations for diagnosing gestational diabetes should be used worldwide. Clin Chem 2012, 58:1094-1097.
18. McIntyre H.D. Diagnosing gestational diabetes mellitus: rationed or rationally related to risk. Diabetes Care 2013, 36:2879-2880.
19. American Diabetes Association Standards of medical care in diabetes-2013. Diabetes Care 2013, 36(Suppl 1):S11-S66.
20. Hoffman L., Nolan C., Wilson J.D., Oats J.J., Simmons D. Gestational diabetes mellitus-management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust 1998, 169:93-97.
21. Walker J.D. NICE guidance on diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. NICE clinical guideline 63. Diabet Med (Lond) 2008, 25:1025-1027.
22. Naylor C.D., Sermer M., Chen E., Farine D. Selective screening for gestational diabetes mellitus. Toronto Trihospital Gestational Diabetes Project Investigators. N Engl J Med 1997, 337:1591-1596.
23. Caliskan E., Kayikcioglu F., Ozturk N., Koc S., Haberal A. A population-based risk factor scoring will decrease unnecessary testing for the diagnosis of gestational diabetes mellitus. Acta Obstet Gynecol Scand 2004, 83:524-530.
24. van Leeuwen M., Opmeer B.C., Zweers E.J., van Ballegooie E., ter Brugge H.G., de Valk H.W., et al. Estimating the risk of gestational diabetes mellitus: a clinical prediction model based on patient characteristics and medical history. BJOG 2010, 117:69-75.
25. Teede H.J., Harrison C.L., Teh W.T., Paul E., Allan C.A. Gestational diabetes: development of an early risk prediction tool to facilitate opportunities for prevention. Aust N Z J Obstet Gynaecol 2011, 51:499-504.
26. Gionet N.J., Godin G. Self-reported exercise behavior of employees: a validity study. J Occup Med 1989, 31:969-973.
27. Forest J.C., Girouard J., Masse J., Moutquin J.M., Kharfi A., Ness R.B., et al. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005, 105:1373-1380.
28. Moisan J., Meyer F., Gingras S. A nested case-control study of the correlates of early menarche. Am J Epidemiol 1990, 132:953-961.
29. Dodin S., Lemay A., Jacques H., Legare F., Forest J.C., Masse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 2005, 90:1390-1397.
30. Doyle M.A., Khan S., Al-Mohanadi D., Keely E. International survey on gestational diabetes. J Matern Fetal Neonatal Med 2012, 25:2035-2038.
31. Gonzalez-Quintero V.H., Istwan N.B., Rhea D.J., Tudela C.M., Flick A.A., de la Torre L., et al. Antenatal factors predicting subsequent need for insulin treatment in women with gestational diabetes. J Womens Health (Larchmt) 2008, 17:1183-1187.
32. Sapienza A.D., Francisco R.P., Trindade T.C., Zugaib M. Factors predicting the need for insulin therapy in patients with gestational diabetes mellitus. Diabetes Res Clin Pract 2010, 88:81-86.
33. Wong V.W., Jalaludin B. Gestational diabetes mellitus: who requires insulin therapy. Aust N Z J Obstet Gynaecol 2011, 51:432-436.
34. Oostdam N., van Poppel M.N., Wouters M.G., van Mechelen W. Interventions for preventing gestational diabetes mellitus: a systematic review and meta-analysis. J Womens Health (Larchmt) 2011, 20:1551-1563.
35. Quinlivan J.A., Lam L.T., Fisher J. A randomised trial of a four-step multidisciplinary approach to the antenatal care of obese pregnant women. Aust N Z J Obstet Gynaecol 2011, 51:141-146.
36. Maher N., McAuliffe F., Foley M. The benefit of early treatment without rescreening in women with a history of gestational diabetes. J Matern Fetal Neonat Med 2013, 26:318-320.
37. Harrison C., Lombard C., Strauss B.J., Teede H.J. Optimising healthy gestational weight gain in women at high risk of gestational diabetes: a randomised controlled trial. Obesity 2012.
38. Ferreira A.F., Rezende J.C., Vaikousi E., Akolekar R., Nicolaides K.H. Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus. Clin Chem 2011, 57:609-613.
39. Nanda S., Savvidou M., Syngelaki A., Akolekar R., Nicolaides K.H. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn 2011, 31:135-141.
40. Savvidou M., Nelson S.M., Makgoba M., Messow C.M., Sattar N., Nicolaides K. First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures. Diabetes 2010, 59:3017-3022.
41. Lovati E., Beneventi F., Simonetta M., Laneri M., Quarleri L., Scudeller L., et al. Gestational diabetes mellitus: including serum pregnancy-associated plasma protein-A testing in the clinical management of primiparous women? A case-control study. Diabetes Res Clin Pract 2013, 100:340-347.